-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | -0.810% | -1.575% | -6.015% | -19.355% | -24.699% | -54.545% | -83.333% |
| Celldex Therapeutics | -1.530% | 1.587% | -12.727% | -11.111% | -12.727% | -50.920% | -9.177% |
| Achieve Life Sciences Inc. | -0.570% | 2.332% | -25.793% | 9.006% | -5.135% | -29.716% | -71.230% |
News
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
It's been a rough start in 2026 for Ark Invest co-founder, CEO, and Chief Investment Officer Cathie Wood. The largest exchange-traded fund at her company is trading 10% lower year to date. The
Is Nvidia Still a Millionaire-Maker?
Investors who got in on Nvidia (NASDAQ: NVDA) stock a few years ago have seen their returns multiply. The stock has climbed 700% over the past three years as the artificial intelligence (AI)
Prediction: Micron's Stock Price Will Be Worth This Much by the End of 2026
Smart investors already know that the artificial intelligence (AI) revolution has served as a generational bellwether for semiconductor stocks. Over the last few years, capital expenditure budgets


